Longeveron Inc. (LGVN)
NASDAQ: LGVN · Real-Time Price · USD
0.541
-0.039 (-6.66%)
At close: Feb 27, 2026, 4:00 PM EST
0.555
+0.014 (2.51%)
After-hours: Feb 27, 2026, 5:14 PM EST
Longeveron Market Cap
Longeveron has a market cap or net worth of $11.55 million as of February 27, 2026. Its market cap has decreased by -50.42% in one year.
Market Cap
11.55M
Enterprise Value
3.29M
1-Year Change
-50.42%
Ranking
Category
Stock Price
$0.54
Market Cap Chart
Since the IPO on February 12, 2021, Longeveron's market cap has decreased from $172.48M to $11.55M, a decrease of -93.30%. That is a compound annual growth rate of -41.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 11.55M | 7.00% |
| Dec 31, 2025 | 10.79M | -57.95% |
| Dec 31, 2024 | 25.67M | -24.83% |
| Dec 29, 2023 | 34.15M | -49.55% |
| Dec 30, 2022 | 67.68M | -72.36% |
| Dec 31, 2021 | 244.90M | 41.99% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kairos Pharma | 12.61M |
| BioLineRx | 12.49M |
| CytoMed Therapeutics | 12.46M |
| Phio Pharmaceuticals | 12.27M |
| Cardio Diagnostics Holdings | 11.96M |
| Soligenix | 11.90M |
| Chemomab Therapeutics | 11.45M |
| Imunon | 11.05M |